[Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?].
Uhl
D
D
D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000187:drug effects*; D043562:Receptors, G-Protein-Coupled
D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor
PAF und PAF-Antagonisten. Neue Wege in der Asthmatherapie?